Literature DB >> 21840367

Cinnamaldehyde protects from the hypertension associated with diabetes.

Hany M El-Bassossy1, Ahmed Fahmy, Dina Badawy.   

Abstract

Here we investigated cinnamaldehyde (CA) effect on diabetes-induced hypertension. Insulin deficiency was induced by streptozotocin while, insulin resistance by fructose. Rats were left 8 weeks or 12 weeks after STZ or fructose administration respectively. CA (20 mg kg(-1)day(-1)) was daily administered in the last 6 weeks. Then, blood pressure (BP) was recorded. Isolated Aorta reactivity to phenylephrine (PE), KCl, acetylcholine (ACh) was studied as well as nitric oxide (NO) generation plus Ca(2+) influx. Insulin deficiency was associated with elevated BP, increased response to PE and KCl, decreased response to ACh and impaired NO generation. CA treatment prevented hyperglycemia and its associated impaired vascular reactivity. Insulin resistance was associated with elevated BP while, CA prevented this elevation. Insulin resistance increased response to PE and KCl, decreased response to ACh, while CA treatment normalized response to KCl and PE but not to ACh. Insulin resistance was accompanied with reduced NO generation but exaggerated Ca(2+) influx while CA restored normal Ca(2+) influx but did not affect NO generation. In conclusion, CA prevents development of hypertension in insulin deficiency and insulin resistance through normalization of vascular contractility in addition to its insulinotropic effect in insulin deficiency.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840367     DOI: 10.1016/j.fct.2011.07.060

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  30 in total

1.  Cinnamaldehyde inhibits L-type calcium channels in mouse ventricular cardiomyocytes and vascular smooth muscle cells.

Authors:  Julio Alvarez-Collazo; Lucía Alonso-Carbajo; Ana I López-Medina; Yeranddy A Alpizar; Sendoa Tajada; Bernd Nilius; Thomas Voets; José Ramón López-López; Karel Talavera; María Teresa Pérez-García; Julio L Alvarez
Journal:  Pflugers Arch       Date:  2014-02-25       Impact factor: 3.657

2.  Effects of diosmin and crocin on metabolic syndrome-associated cardio-vascular complications in rats.

Authors:  Rania El-Fawal; Hassan M El Fayoumi; Mona F Mahmoud
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-07-27       Impact factor: 3.000

3.  Cinnamaldehyde exerts vasculoprotective effects in hypercholestrolemic rabbits.

Authors:  Omnia A A Nour; George S G Shehatou; Mona Abdel Rahim; Mohammed S El-Awady; Ghada M Suddek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-07-30       Impact factor: 3.000

Review 4.  Nrf2: a potential therapeutic target for diabetic neuropathy.

Authors:  Anil Kumar; Ruchika Mittal
Journal:  Inflammopharmacology       Date:  2017-03-28       Impact factor: 4.473

5.  Pentoxifylline alleviates hypertension in metabolic syndrome: effect on low-grade inflammation and angiotensin system.

Authors:  A Azhar; H M El-Bassossy
Journal:  J Endocrinol Invest       Date:  2014-11-21       Impact factor: 4.256

6.  Differential effects of high consumption of fructose or glucose on mesenteric arterial function in female rats.

Authors:  Sonali Shaligram; Gemma Sangüesa; Farjana Akther; Marta Alegret; Juan C Laguna; Roshanak Rahimian
Journal:  J Nutr Biochem       Date:  2018-04-03       Impact factor: 6.048

7.  Heme oxygenase-1 induction protects against hypertension associated with diabetes: effect on exaggerated vascular contractility.

Authors:  N Hassan; H M El-Bassossy; M N M Zakaria
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-20       Impact factor: 3.000

8.  Arginase inhibition alleviates hypertension in the metabolic syndrome.

Authors:  Hany M El-Bassossy; Rania El-Fawal; Ahmed Fahmy; Malcolm L Watson
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

9.  Tempol ameliorates cardiac fibrosis in streptozotocin-induced diabetic rats: role of oxidative stress in diabetic cardiomyopathy.

Authors:  Ashraf Taye; Mekky M Abouzied; Omar M M Mohafez
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-08-16       Impact factor: 3.000

10.  Cinnamaldehyde attenuates pressure overload-induced cardiac hypertrophy.

Authors:  Liu Yang; Qing-Qing Wu; Yuan Liu; Zhe-Fu Hu; Zhou-Yan Bian; Qi-Zhu Tang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.